Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Perspectives on technology - prostate cancer: is local anaesthetic transperineal prostate biopsy really better than transrectal biopsy?

Berridge C. et al, (2024), BJU Int

A phase I open-label, dose-escalation study of NUC-3373, a targeted thymidylate synthase inhibitor, in patients with advanced cancer (NuTide:301).

Spiliopoulou P. et al, (2024), J Exp Clin Cancer Res, 43

From Data to Diagnosis: Skin Cancer Image Datasets for Artificial Intelligence.

Wen D. et al, (2024), Clin Exp Dermatol

New role of fat-free mass in cancer risk linked with genetic predisposition.

Harris BHL. et al, (2024), Sci Rep, 14

Phenotypic screen of sixty-eight colorectal cancer cell lines identifies CEACAM6 and CEACAM5 as markers of acid resistance.

Michl J. et al, (2024), Proc Natl Acad Sci U S A, 121

Dosimetric validation of SmART-RAD Monte Carlo modelling for x-ray cabinet radiobiology irradiators

Hill MA. et al, (2024), Physics in Medicine & Biology

Oncological outcomes of patients with oligometastatic oesophagogastric cancer.

Down B. et al, (2024), Eur J Surg Oncol, 50

A Phase I Study of the Oral Dual-Acting Pan-PI3K/mTOR Inhibitor Bimiralisib in Patients with Advanced Solid Tumors

Janku F. et al, (2024), Cancers, 16

JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors.

Pennel KAF. et al, (2024), J Exp Clin Cancer Res, 43

The AsiDNA™ decoy mimicking DSBs protects the normal tissue from radiation toxicity through a DNA-PK/p53/p21-dependent G1/S arrest.

Sesink A. et al, (2024), NAR Cancer, 6

Systemic interrogation of immune-oncology-related proteins in patients with locally advanced prostate cancer undergoing androgen deprivation and intensity-modulated radiotherapy.

Guldvik IJ. et al, (2024), World J Urol, 42

Intra-prostatic tumour evolution, steps in metastatic spread and histogenomic associations revealed by integration of multi-region whole-genome sequencing with histopathological features.

Rao S. et al, (2024), Genome Med, 16

Correcting PCR amplification errors in unique molecular identifiers to generate accurate numbers of sequencing molecules

Sun J. et al, (2024), Nature Methods

Cancer Precision-Prevention trial of Metformin in adults with Li Fraumeni syndrome (MILI) undergoing yearly MRI surveillance: a randomised controlled trial protocol.

Dixon-Zegeye M. et al, (2024), Trials, 25

Mitigating Machine Learning Bias Between High Income and Low-Middle Income Countries for Enhanced Model Fairness and Generalizability

Yang J. et al, (2024)

Reconfiguring a Plane-Parallel Transmission Ionization Chamber to Extend the Operating Range into the Ultra-High Dose-per-pulse Regime.

Konradsson E. et al, (2024), Radiat Res

Leveraging GWAS: Path to Prevention? - Letter.

Peters U. and Tomlinson I., (2024), Cancer Prev Res (Phila), 17

Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II-III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysis.

Frei AL. et al, (2024), Lancet Oncol, 25, 198 - 211

Focused Screening Identifies Different Sensitivities of Human TET Oxygenases to the Oncometabolite 2-Hydroxyglutarate.

Belle R. et al, (2024), J Med Chem

BLM and BRCA1-BARD1 coordinate complementary mechanisms of joint DNA molecule resolution.

Tsukada K. et al, (2024), Mol Cell

Load More

1
2
3
4
5
6
7
...
»